PPAR-γ ligands inhibit the cellular proliferation of pancreatic cancer, a process comparable with the terminal differentiation induced by cessation of cell proliferation and the accumulation of cells in the G1 phase of the cell cycle (20). This evidence concerns the gene PPARG and familial pancreatic carcinoma.